ENOV logo

ENOVIS CORP

ENOVNYSE
πŸ† #2228 by market capEarnings Nov 5US Equity
$21.91β–² $0.37 (+1.72%)
Market closed Β· at close
πŸ””
Track ENOV
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.7%
7dβ–² 1.4%
14dβ–² 13.3%
30dβ–² 18.7%
ytdβ–Ό 17.7%
1yβ–Ό 31.5%
🏦Market Cap
$1.26B
Small Cap
πŸ“ˆRevenue Growth (YoY)
6.7%
Slowing
πŸ“ŠGross Margin
57.4%
Healthy
πŸ’΅FCF Margin
2.8%
Thin
βš–οΈP/S Ratio
0.6x
Cheap
Otter Score
76
Strong

Trading Snapshot

Day Range
$21.46 – $22.29
52-Week Range
$16.70 – $33.13
Volume (shares)
1,175,547
Avg Volume (shares)
β€”
Shares Outstanding
57.7M
Next Earnings
2026-11-05

Fundamentals Snapshot

Annual Revenue
$2.25B
Last Q Revenue
$583M
P/E Ratio
-1.1
P/S Ratio
0.6x
EPS (TTM)
$-19.13
Dividend Yield
0.00%
Dilution (1yr)
βˆ’2.7%
ENOV logo

ENOVIS CORP

ENOV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2.2Bβ–² +6.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
59.8%β–² +6.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$19Mβ–Ό βˆ’97.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$20Mβ–Ό βˆ’129.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
56.8Mβ–Ό βˆ’2.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$1.3Bβ–² +$13M YoY
StockOtter Β· stockotter.space

About ENOVIS CORP

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionalsβ€”including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainersβ€”who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100
Analyst data unavailable.

Latest News & Updates

GlobeNewsWireΒ·20d ago

Enovis to Host Third Quarter 2026 Results Conference Call on November 5th

Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovisβ„’ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss

Defense WorldΒ·22d ago

electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison

electroCore (NASDAQ: ECOR - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the stren

Defense WorldΒ·23d ago

Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)

Nexalin Technology (NASDAQ: NXL - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the

PRNewsWireΒ·Sep 22

Enovis becomes first multi-registry industry sponsor of AAOS Registry Program

Company expands its support from the American Joint Replacement Registry to include the Shoulder & Elbow Registry ROSEMONT, Ill., Sept. 22, 2026 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announc

Defense WorldΒ·Sep 16

Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next?

Enovis Corporation (NYSE: ENOV - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $17.30 and last traded at $17.9220, with a volume of 2658431 share

Fool - Investing NewsΒ·Sep 14

Insider at Medical Device Maker Buys More Than 7,500 Shares

Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.